Work

Immunomodulatory potential of dexmedetomidine in perioperative pain management for patients with cancer

Year: 2025
Type: article
Abstract: •Dexmedetomidine (DEX) has immunomodulatory effects in perioperative pain management.•DEX can reduce pro-inflammatory cytokines.•DEX has dose-dependent effects on tumor progression.•Optimizing DEX dosing may improve the therapeutic outcomes of cancer surgery.•Further research is needed to clarify DEX's impact on cancer recurrence and survival, as the findings remain mixed.
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $1,100
OpenAlex ID: W4406072002
FWCI: 1.022
Cites: 21
Cited by: 4
Related to: 10